Hensoldt AG
Hensoldt AG (HNSDF) Financial Performance & Income Statement Overview
Analyze Hensoldt AG (HNSDF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Hensoldt AG (HNSDF) Income Statement & Financial Overview
Review Hensoldt AG HNSDF income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $395.00M | $864.00M | $527.00M | $520.00M |
| Cost of Revenue | $339.00M | $627.00M | $416.00M | $419.00M |
| Gross Profit | $56.00M | $237.00M | $111.00M | $101.00M |
| Gross Profit Ratio | $0.14 | $0.27 | $0.21 | $0.19 |
| R&D Expenses | $8.00M | $6.00M | $0.00 | $9.00M |
| SG&A Expenses | $64.00M | $83.00M | $71.00M | $78.00M |
| Operating Expenses | $74.00M | $90.00M | $111.00M | $87.00M |
| Total Costs & Expenses | $413.00M | $717.00M | $495.00M | $506.00M |
| Interest Income | $6.00M | $7.00M | -$6.00M | $11.00M |
| Interest Expense | $25.00M | $26.00M | $29.00M | $26.00M |
| Depreciation & Amortization | $38.00M | $53.00M | $37.00M | $43.00M |
| EBITDA | $25.00M | $204.00M | $66.00M | $71.00M |
| EBITDA Ratio | $0.06 | $0.24 | $0.13 | $0.14 |
| Operating Income | -$18.00M | $147.00M | $32.00M | $14.00M |
| Operating Income Ratio | -$0.05 | $0.17 | $0.06 | $0.03 |
| Other Income/Expenses (Net) | -$20.00M | -$22.00M | -$32.00M | -$12.00M |
| Income Before Tax | -$38.00M | $125.00M | $0.00 | $2.00M |
| Income Before Tax Ratio | -$0.10 | $0.14 | $0.00 | $0.004 |
| Income Tax Expense | -$7.00M | -$28.00M | $22.00M | $12.00M |
| Net Income | -$30.00M | $154.00M | -$21.00M | -$10.00M |
| Net Income Ratio | -$0.08 | $0.18 | -$0.04 | -$0.02 |
| EPS | -$0.26 | $1.33 | -$0.18 | -$0.09 |
| Diluted EPS | -$0.26 | $1.33 | -$0.18 | -$0.09 |
| Weighted Avg Shares Outstanding | $115.38M | $115.50M | $115.50M | $115.50M |
| Weighted Avg Shares Outstanding (Diluted) | $115.38M | $115.50M | $115.50M | $115.50M |
Over the past four quarters, Hensoldt AG demonstrated steady revenue growth, increasing from $520.00M in Q2 2024 to $395.00M in Q1 2025. Operating income reached -$18.00M in Q1 2025, maintaining a consistent -5% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $25.00M, reflecting operational efficiency. Net income dropped to -$30.00M, with EPS at -$0.26. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan